111,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
56 °P sammeln
  • Broschiertes Buch

Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective…mehr

Produktbeschreibung
Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs. Despite recent advances in our understanding of lung cancer and the implementation of many new preventive measures, this terrible disease remains the leading cause of cancer deaths in the United States, as well as a major cause of such deaths worldwide. In Cancer of the Lung: From Molecular Biology to Treatment Guidelines, Alan B. Weitberg, MD, and a panel of internationally recognized basic scientists and clinicians present a comprehensive discussion of lung cancer, including a practice-oriented review of its diagnosis, evaluation, and treatment. The contributors offer not only an understandable description of its molecular origins-an essential key to developing future therapies and preventive measures-but also rigorously discuss already well-tested approaches, as well as those that are currently being evaluated for future use in both the laboratory and clinic. The book also elucidates the creation and effective deployment of treatment guidelines introduced by third party payers to improve clinical outcomes, even while lowering healthcare costs, including those entailed by malpractice litigation.
Comprehensive and highly readable, Cancer of the Lung: From Molecular Biology to Treatment Guidelines offers today's oncologists, internists, and residents not only a clear and concise introduction to its molecular biology, but also a state-of-the-art practical review of all the current and developing diagnostic and treatment options for patients.
Rezensionen
"The fourteen chapters are edited into conformity where the elements in any chapter are clearly headed an numbered so that it is unusually easy to find ones way about. In addition, there is a complete an up to date bibliography of references attached to each chapter. The most fascinating...part of the book is the opening section where the etiology, pathology and molecular biology are described." - Journal of the Royal College of Surgeons of Edinburgh "...a comprehensive but succinct review of accumulated knowledge and an able literature updte in a field that undergoes constant evolution...readable and useful reference that earns its place in the literature." Doody's Health Sciences Book Review Journal "...the book is well-written, and provides brief but quite comprehensive summaries of the relevant areas...well worth reading for all those with an interest in the important biological and clinical issues in lung cancer management." - Cancer Forum